Abstract:OBJECTIVE: RNA interference (RNAi) refers to the phenomenon of sequence‐specific degradation of homologous mRNA induced by double‐stranded RNA. It has been successfully utilized to down‐regulate endogenous gene expression or suppress the replication of various pathogens in mammalian cells. In this study, the effect of vector‐based small interfering RNA (siRNA) promoted by pSilencer2.0‐U6 inhibit hepatitis B virus (HBV) replication in cell culture was evaluated. METHODS: Three fragments of short nucleic acids, respectively, targeting on S, X and C region of HBV genome were inserted into pSilencer vectors after they were annealed with their partly antisense strands. The recombination plasmids were pS, pX and pC. These expression plasmids were transfected into HepG2‐N10 cells, a cell line which stably expresses hepatitis B virus surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg) and adw2 subtype Dane particles. The effect of RNAi was evaluated from the changes of DNA, RNA and protein levels. Viral antigens were measured by ELISA. Viral mRNA was analyzed by RT‐PCR. The covalent closed circular DNA and genome DNA of HBV secreted into the culture media were measured by quantitative real‐time PCR. Analysis of variance was performed for the results. RESULTS: Vector‐based RNA interference could potently reduce HBsAg (pS vs pN: 47%, pX vs pN: 30%, and pC vs pN: 25%, P < 0.001) and HBeAg (pX vs pN: 57% and pC vs pN: 66%, P < 0.001) expression in cell culture. Furthermore, RT‐PCR analysis showed that viral mRNAs were effectively degraded, thus eliminating the messengers for protein expression as well as templates for reverse transcription (pS and pC vs pN, P < 0.001; pX vs pN, P = 0.003). Quantitative real‐time PCR analysis of HBV DNA revealed that vector‐based RNA interference can inhibit HBV replication efficiently (pS, pX and pC vs pN, P < 0.001). CONCLUSIONS: Our results indicate that RNAi can inhibit HBV gene expression and replication, and it might have the potential to revolutionize the treatment of HBV.

Inhibition of hepatitis viral replication by siRNA.

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

INHIBITION OF HEPATITIS B VIRUS BY COMBINED Sirnas IN VITRO

Inhibition of Hepatitis C Virus Replication and Expression by Small Interfering Rna Targeting Host Cellular Genes

Inhibition of Hepatitis B Virus Replication by Recombinant Small Interfering RNAs.

Effective Inhibition of Hepatitis B Virus Replication by Small Interfering RNAs Expressed from Human Foamy Virus Vectors.

Inhibition of Hepatitis B Virus Replication by Various RNAi Constructs and Their Pharmacodynamic Properties

Stable Inhibition of Hepatitis B Virus Expression and Replication by Expressed Sirna

[Inhibition of Hepatitis B Virus Replication and Expression by RNA Interference in Vivo].

Inhibition of Hepatitis B virus replication by small interfering RNA in vivo

RNA Interference inhibits Hepatitis B Virus of different genotypes in Vitro and in Vivo

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Inhibition of HBV Replication by Small Interference RNA in HepG2.2.15 Cells

[Inhibition of hepatitis C virus replication by small interfering RNA in cells infected by HCV].

RNA Interference Inhibits Hepatitis B Virus Gene Expression and Replication in HepG2-N10 Cells

Sirna-Mediated Inhibition of Hbv Replication and Expression

Inhibition of Hepatitis B Virus Replication and Expression by Small Interfering RNA in Mice Targeting S Gene Region and C Gene Region

Inhibition of Hepatitis C Virus Replication by Single and Dual Small Interfering RNA Using an HCV-infected Cell Model

Hepatitis B Virus Inhibition in Mice by Lentiviral Vector Mediated Short Hairpin RNA.

Combination of Small Interfering RNAs Mediates Greater Inhibition of Human Hepatitis B Virus Replication and Antigen Expression

Inhibition of Hepatitis B Virus by Small Interfering RNAs Expressed from Human Foamy Virus Vectors